ERYTECH verkündet zuvor auf Jahrestagung der American Society of Hematology präsentierte positive Ergebnisse der Phase-II-Studie von Eryaspase bei akuter lymphoblastischer Leukämie

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing